The Patent Finder

Coimmune, Inc.

Also on record
Records under this name other than the patents Coimmune, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Back to Coimmune, Inc.

PatentTitleStatus Expires Confidence
US 10,022,731Centrifuge Vessels with a Center Mound and an Internal Elongate Tube Suitable for Live Cell Processing and Associated Systems and Methods
Lapsed on the fee record
Ended Jul 17, 2026 · High confidence
Lapsed on the fee recordEnded Jul 17, 2026High confidence
US 9,970,068Primers and probes for the amplification and detection of HIV GAG, REV and NEF polynucleotides
Lapsed on the fee record
Ended May 15, 2026 · From the USPTO record
Lapsed on the fee recordEnded May 15, 2026From the USPTO record
US 9,102,726Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same
Term ended
Term ended Mar 27, 2026 · From the USPTO record
Term endedTerm ended Mar 27, 2026From the USPTO record
US 8,672,879Devices, systems and related methods suitable for delivery of a liquid medicament stored at cryogenic temperatures
Lapsed on the fee record
Ended Mar 18, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2026From the USPTO record
US 8,658,771Humanized Antibodies Against Human Interferon-Alpha
Lapsed on the fee record
Ended Feb 25, 2026 · Medium confidence
Lapsed on the fee recordEnded Feb 25, 2026Medium confidence
US 11,248,209Mature Dendritic Cell Compositions and Methods for Culturing Same
Lapsed on the fee record
Ended Feb 15, 2026 · High confidence
Lapsed on the fee recordEnded Feb 15, 2026High confidence
US 8,822,223Mature Dendritic Cell Compositions and Methods for Culturing Same
Term ended
Term ended Feb 12, 2026 · Medium confidence
Term endedTerm ended Feb 12, 2026Medium confidence
US 9,879,053Strain-independent amplification of pathogens and vaccines thereto
Term ended
Term ended Jan 9, 2026 · From the USPTO record
Term endedTerm ended Jan 9, 2026From the USPTO record
US 10,184,108Mature Dendritic Cell Compositions and Methods for Culturing Same
Term ended
Term ended Oct 7, 2025 · Medium confidence
Term endedTerm ended Oct 7, 2025Medium confidence
US 7,785,583In situ maturation of dendritic cells
Term ended
Term ended Sep 1, 2025 · From the USPTO record
Term endedTerm ended Sep 1, 2025From the USPTO record
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited